Palvella Therapeutics, Inc (PVLA) financials · $1.64B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Palvella Therapeutics, Inc (PVLA) $1.64B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$38.6M | -$14.1M |
| Net Income | -$41.7M | -$17.4M |
| EPS (Diluted) | -$3.71 | -$7.83 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $59.6M | $88.2M |
| Current Assets | $59.0M | $88.2M |
| Cash & Equivalents | $58.0M | $83.6M |
| Total Liabilities | $31.6M | $25.6M |
| Current Liabilities | $11.3M | $12.0M |
| Shareholders' Equity | $28.0M | $62.6M |
| Retained Earnings | -$135.4M | -$93.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$25.0M | -$10.8M |
| Financing Cash Flow | -$660.0K | $87.1M |
| Net Change in Cash | -$25.6M | $76.3M |
FAQ
What is PVLA P/E and revenue?
Palvella Therapeutics, Inc (PVLA) $1.64B cap.
What is PVLA revenue?
PVLA income-statement cache has no revenue figure yet.
Is PVLA profitable?
Palvella Therapeutics, Inc last cached net income is -$41.7M (FY2025).
What are PVLA total assets?
Palvella Therapeutics, Inc last cached total assets are $59.6M (FY2025).
What is PVLA free cash flow?
No cached cash-flow row for PVLA yet.
Not investment advice. Cached statements, not a live tape.